OBJECTIVES: HIV-1 subtypes A1 and D cocirculate in a rural community in Mbarara, Uganda. This study examines HIV-1 intersubtype recombination in this community under a full-genome sequencing context. We aim to estimate prevalence, examine time trends, and test for clinical correlates and outcomes associated with intersubtype recombinants. METHODS: Near-full-genome HIV-1 Sanger sequence data were collected from plasma samples of 504 treatment-naïve individuals, who then received protease inhibitor or nonnucleoside reverse transcriptase inhibitor-containing regimens and were monitored for up to 7.5 years. Subtypes were inferred by Los Alamos Recombinant Identification Program (RIP) 3.0 and compared with Sanger/REGA and MiSeq/RIP. 'Nonrecombinants' and 'recombinants' infections were compared in terms of pretherapy viral load, CD4 cell count, posttherapy time to virologic suppression, virologic rebound, first CD4 rise above baseline and sustained CD4 recovery. RESULTS: Prevalence of intersubtype recombinants varied depending on the genomic region examined: gag (15%), prrt (11%), int (8%), vif (10%), vpr (2%), vpu (9%), GP120 (8%), GP41 (18%), and nef (4%). Of the 200 patients with near-full-genome data, prevalence of intersubtype recombination was 46%; the most frequently observed recombinant was A1-D (25%). Sanger/REGA and MiSeq/RIP yielded generally consistent results. Phylogenetic tree revealed most recombinants did not share common ancestors. No temporal trend was observed (all P > 0.1). Subsequent subtype switches were detected in 27 of 143 (19%) study participants with follow-up sequences. Nonrecombinant versus recombinants infections were not significantly different in any pre nor posttherapy clinical correlates examined (all P > 0.2). CONCLUSION: Intersubtype recombination was highly prevalent (46%) in Uganda if the entire HIV genome was considered, but was neither associated with clinical correlates nor therapy outcomes.
OBJECTIVES:HIV-1 subtypes A1 and D cocirculate in a rural community in Mbarara, Uganda. This study examines HIV-1 intersubtype recombination in this community under a full-genome sequencing context. We aim to estimate prevalence, examine time trends, and test for clinical correlates and outcomes associated with intersubtype recombinants. METHODS: Near-full-genome HIV-1 Sanger sequence data were collected from plasma samples of 504 treatment-naïve individuals, who then received protease inhibitor or nonnucleoside reverse transcriptase inhibitor-containing regimens and were monitored for up to 7.5 years. Subtypes were inferred by Los Alamos Recombinant Identification Program (RIP) 3.0 and compared with Sanger/REGA and MiSeq/RIP. 'Nonrecombinants' and 'recombinants' infections were compared in terms of pretherapy viral load, CD4 cell count, posttherapy time to virologic suppression, virologic rebound, first CD4 rise above baseline and sustained CD4 recovery. RESULTS: Prevalence of intersubtype recombinants varied depending on the genomic region examined: gag (15%), prrt (11%), int (8%), vif (10%), vpr (2%), vpu (9%), GP120 (8%), GP41 (18%), and nef (4%). Of the 200 patients with near-full-genome data, prevalence of intersubtype recombination was 46%; the most frequently observed recombinant was A1-D (25%). Sanger/REGA and MiSeq/RIP yielded generally consistent results. Phylogenetic tree revealed most recombinants did not share common ancestors. No temporal trend was observed (all P > 0.1). Subsequent subtype switches were detected in 27 of 143 (19%) study participants with follow-up sequences. Nonrecombinant versus recombinants infections were not significantly different in any pre nor posttherapy clinical correlates examined (all P > 0.2). CONCLUSION: Intersubtype recombination was highly prevalent (46%) in Uganda if the entire HIV genome was considered, but was neither associated with clinical correlates nor therapy outcomes.
Authors: D L Robertson; J P Anderson; J A Bradac; J K Carr; B Foley; R K Funkhouser; F Gao; B H Hahn; M L Kalish; C Kuiken; G H Learn; T Leitner; F McCutchan; S Osmanov; M Peeters; D Pieniazek; M Salminen; P M Sharp; S Wolinsky; B Korber Journal: Science Date: 2000-04-07 Impact factor: 47.728
Authors: Matthew E Harris; David Serwadda; Nelson Sewankambo; Bohye Kim; Godfrey Kigozi; Noah Kiwanuka; James B Phillips; Fred Wabwire; Mary Meehen; Tom Lutalo; James R Lane; Randall Merling; Ron Gray; Maria Wawer; Deborah L Birx; Merlin L Robb; Francine E McCutchan Journal: AIDS Res Hum Retroviruses Date: 2002-11-20 Impact factor: 2.205
Authors: Conan K Woods; Chanson J Brumme; Tommy F Liu; Celia K S Chui; Anna L Chu; Brian Wynhoven; Tom A Hall; Christina Trevino; Robert W Shafer; P Richard Harrigan Journal: J Clin Microbiol Date: 2012-03-07 Impact factor: 5.948
Authors: Peter W Hunt; Huyen L Cao; Conrad Muzoora; Isaac Ssewanyana; John Bennett; Nneka Emenyonu; Annet Kembabazi; Torsten B Neilands; David R Bangsberg; Steven G Deeks; Jeffrey N Martin Journal: AIDS Date: 2011-11-13 Impact factor: 4.177
Authors: Helen Byakwaga; Yap Boum; Yong Huang; Conrad Muzoora; Annet Kembabazi; Sheri D Weiser; John Bennett; Huyen Cao; Jessica E Haberer; Steven G Deeks; David R Bangsberg; Joseph M McCune; Jeffrey N Martin; Peter W Hunt Journal: J Infect Dis Date: 2014-02-28 Impact factor: 5.226
Authors: Diane E Bennett; Ricardo J Camacho; Dan Otelea; Daniel R Kuritzkes; Hervé Fleury; Mark Kiuchi; Walid Heneine; Rami Kantor; Michael R Jordan; Jonathan M Schapiro; Anne-Mieke Vandamme; Paul Sandstrom; Charles A B Boucher; David van de Vijver; Soo-Yon Rhee; Tommy F Liu; Deenan Pillay; Robert W Shafer Journal: PLoS One Date: 2009-03-06 Impact factor: 3.240
Authors: Viviane D Lima; Josie Geller; David R Bangsberg; Thomas L Patterson; Mark Daniel; Thomas Kerr; Julio S G Montaner; Robert S Hogg Journal: AIDS Date: 2007-05-31 Impact factor: 4.177
Authors: Gonzalo Yebra; Manon Ragonnet-Cronin; Deogratius Ssemwanga; Chris M Parry; Christopher H Logue; Patricia A Cane; Pontiano Kaleebu; Andrew J Leigh Brown Journal: J Gen Virol Date: 2015-02-27 Impact factor: 3.891
Authors: Kevin B Einkauf; Guinevere Q Lee; Ce Gao; Radwa Sharaf; Xiaoming Sun; Stephane Hua; Samantha My Chen; Chenyang Jiang; Xiaodong Lian; Fatema Z Chowdhury; Eric S Rosenberg; Tae-Wook Chun; Jonathan Z Li; Xu G Yu; Mathias Lichterfeld Journal: J Clin Invest Date: 2019-01-28 Impact factor: 14.808
Authors: Francesco R Simonetti; Hao Zhang; Garshasb P Soroosh; Jiayi Duan; Kyle Rhodehouse; Alison L Hill; Subul A Beg; Kevin McCormick; Hayley E Raymond; Christopher L Nobles; John K Everett; Kyungyoon J Kwon; Jennifer A White; Jun Lai; Joseph B Margolick; Rebecca Hoh; Steven G Deeks; Frederic D Bushman; Janet D Siliciano; Robert F Siliciano Journal: J Clin Invest Date: 2021-02-01 Impact factor: 14.808
Authors: Lucie Abeler-Dörner; Mary K Grabowski; Andrew Rambaut; Deenan Pillay; Christophe Fraser Journal: Curr Opin HIV AIDS Date: 2019-05 Impact factor: 4.283
Authors: Adam A Capoferri; Susanna L Lamers; Mary Kate Grabowski; Rebecca Rose; Maria J Wawer; David Serwadda; Ronald H Gray; Thomas C Quinn; Godfrey Kigozi; Joseph Kagaayi; Oliver Laeyendecker Journal: AIDS Res Hum Retroviruses Date: 2020-03-02 Impact factor: 2.205
Authors: Deogratius Ssemwanga; Nicholas Bbosa; Rebecca N Nsubuga; Alfred Ssekagiri; Anne Kapaata; Maria Nannyonjo; Faridah Nassolo; Alex Karabarinde; Joseph Mugisha; Janet Seeley; Gonzalo Yebra; Andrew Leigh Brown; Pontiano Kaleebu Journal: Viruses Date: 2020-11-10 Impact factor: 5.048
Authors: Marion Pardons; Linos Vandekerckhove; Basiel Cole; Laurens Lambrechts; Pierre Gantner; Ytse Noppe; Noah Bonine; Wojciech Witkowski; Lennie Chen; Sarah Palmer; James I Mullins; Nicolas Chomont Journal: Nat Commun Date: 2021-06-17 Impact factor: 14.919
Authors: Heather E Grant; Emma B Hodcroft; Deogratius Ssemwanga; John M Kitayimbwa; Gonzalo Yebra; Luis Roger Esquivel Gomez; Dan Frampton; Astrid Gall; Paul Kellam; Tulio de Oliveira; Nicholas Bbosa; Rebecca N Nsubuga; Freddie Kibengo; Tsz Ho Kwan; Samantha Lycett; Rowland Kao; David L Robertson; Oliver Ratmann; Christophe Fraser; Deenan Pillay; Pontiano Kaleebu; Andrew J Leigh Brown Journal: Virus Evol Date: 2020-02-11
Authors: Eva Malatinkova; Jordan Thomas; Ward De Spiegelaere; Sofie Rutsaert; Anna Maria Geretti; Georgios Pollakis; William A Paxton; Linos Vandekerckhove; Alessandra Ruggiero Journal: Life (Basel) Date: 2021-12-16